Connection

PETER HIATT to Cystic Fibrosis

This is a "connection" page, showing publications PETER HIATT has written about Cystic Fibrosis.
Connection Strength

1.684
  1. Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis. J Cyst Fibros. 2022 03; 21(2):348-352.
    View in: PubMed
    Score: 0.155
  2. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999 Mar; 103(3):619-26.
    View in: PubMed
    Score: 0.131
  3. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics. 1998 Jun; 101(6):1013-9.
    View in: PubMed
    Score: 0.124
  4. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J. 1996 Jan; 15(1):23-31.
    View in: PubMed
    Score: 0.105
  5. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros. 2014 Dec; 13(6):674-80.
    View in: PubMed
    Score: 0.096
  6. Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis. Eur Respir J. 2013 Dec; 42(6):1545-52.
    View in: PubMed
    Score: 0.088
  7. Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J Clin Microbiol. 2013 Apr; 51(4):1237-40.
    View in: PubMed
    Score: 0.085
  8. Lung function from infancy to preschool in a cohort of children with cystic fibrosis. Eur Respir J. 2013 Jan; 41(1):60-6.
    View in: PubMed
    Score: 0.082
  9. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr Pulmonol. 2012 Jun; 47(6):597-605.
    View in: PubMed
    Score: 0.079
  10. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun; 47(6):574-81.
    View in: PubMed
    Score: 0.079
  11. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med. 2011 Sep; 165(9):847-56.
    View in: PubMed
    Score: 0.078
  12. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med. 2010 Dec 01; 182(11):1387-97.
    View in: PubMed
    Score: 0.072
  13. Bronchodilator responsiveness in infants and young children with cystic fibrosis. Am Rev Respir Dis. 1988 Jan; 137(1):119-22.
    View in: PubMed
    Score: 0.060
  14. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol. 2007 Jul; 42(7):610-23.
    View in: PubMed
    Score: 0.058
  15. Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatr Pulmonol. 2007 Jan; 42(1):66-74.
    View in: PubMed
    Score: 0.056
  16. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol. 2003 Dec; 5(12):1341-9.
    View in: PubMed
    Score: 0.045
  17. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
    View in: PubMed
    Score: 0.044
  18. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med. 2003 Mar 15; 167(6):841-9.
    View in: PubMed
    Score: 0.042
  19. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001 Nov; 32(5):356-66.
    View in: PubMed
    Score: 0.039
  20. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001 Feb 01; 183(3):444-52.
    View in: PubMed
    Score: 0.037
  21. T-tube ileostomy for meconium ileus: four decades of experience. J Pediatr Surg. 2000 Feb; 35(2):349-52.
    View in: PubMed
    Score: 0.035
  22. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol. 1999 Nov; 28(5):321-8.
    View in: PubMed
    Score: 0.034
  23. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. Pediatr Infect Dis J. 1998 Mar; 17(3):217-24.
    View in: PubMed
    Score: 0.030
  24. Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr Pulmonol. 1988; 5(1):15-8.
    View in: PubMed
    Score: 0.015
  25. Total respiratory system compliance in asymptomatic infants with cystic fibrosis. Am Rev Respir Dis. 1987 May; 135(5):1075-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.